异动解读 | 维亚生物盘中大涨5.15%,AI制药业务前景看好

异动解读
Aug 29

港股维亚生物(01873)今日盘中大涨5.15%,引发市场关注。分析人士认为,这波涨势很可能与公司在人工智能(AI)制药领域的布局有关。

据了解,维亚生物早在5年前就已开始布局AI制药业务。目前,公司AI相关订单占新签订单的12%,且呈现增长趋势。维亚生物不仅拥有自研的AI和计算机辅助药物设计(CADD)平台,还具备多种药物形态的研发经验。更值得注意的是,公司正在从以计算方法为各个药物研发阶段赋能为主,向以AI驱动药物设计、改变药物设计范式的新阶段迈进。

近期,全球AI制药领域持续升温,多家科技巨头和制药公司纷纷加大在这一领域的投入。在此背景下,作为港股市场中较早布局AI制药的公司之一,维亚生物的投资价值受到市场青睐。随着公司AI制药业务的持续发展和商业化进程的加速,投资者对其未来前景持积极态度,推动了股价的上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10